These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35909973)

  • 41. Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations.
    Lim HJ; Park MY; Jung HS; Kwon Y; Kim I; Kim DK; Yu N; Sung N; Lee SH; Park JE; Yang YJ
    PLoS One; 2021; 16(12):e0260850. PubMed ID: 34905589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI).
    Caza M; Hogan CA; Jassem A; Prystajecky N; Hadzic A; Wilmer A
    J Clin Virol; 2021 Nov; 144():104996. PubMed ID: 34628158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance evaluation of Novaplex SARS-CoV-2 variants assay kit series for SARS-CoV-2 detection using single nucleotide polymorphisms.
    Ogihara S; Aoki K; Nagashima M; Sadamasu K; Ishii Y; Tateda K
    Access Microbiol; 2022; 4(10):acmi000447. PubMed ID: 36415740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
    Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
    Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of Major SARS-CoV-2 Variants of Concern in Clinical Samples via CRISPR-Cas12a-Mediated Mutation-Specific Assay.
    Liang Y; Zou L; Lin H; Li B; Zhao J; Wang H; Sun J; Chen J; Mo Y; Yang X; Deng X; Tang S
    ACS Synth Biol; 2022 May; 11(5):1811-1823. PubMed ID: 35481381
    [No Abstract]   [Full Text] [Related]  

  • 46. Performance verification of five commercial RT-qPCR diagnostic kits for SARS-CoV-2.
    Yang M; Cao S; Liu Y; Zhang Z; Zheng R; Li Y; Zhou J; Zong C; Cao D; Qin X
    Clin Chim Acta; 2022 Jan; 525():46-53. PubMed ID: 34902345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Rapid Antigen Detection Test for SARS-CoV-2 Underestimates the Identification of COVID-19 Positive Cases and Compromises the Diagnosis of the SARS-CoV-2 (K417N/T, E484K, and N501Y) Variants.
    Barrera-Avalos C; Luraschi R; Vallejos-Vidal E; Mella-Torres A; Hernández F; Figueroa M; Rioseco C; Valdés D; Imarai M; Acuña-Castillo C; Reyes-López FE; Sandino AM
    Front Public Health; 2021; 9():780801. PubMed ID: 35047474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.
    Trobajo-Sanmartín C; Miqueleiz A; Portillo ME; Fernández-Huerta M; Navascués A; Sola Sara P; López Moreno P; Ordoñez GR; Castilla J; Ezpeleta C
    J Clin Microbiol; 2021 Nov; 59(12):e0173621. PubMed ID: 34495709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.
    Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF
    Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations.
    Almeida LT; Gonçalves AB; Franco-Luiz APM; Silva TBS; Alves PA; Monte-Neto RLD
    Mem Inst Oswaldo Cruz; 2022; 117():e220050. PubMed ID: 35766650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid and accurate detection of SARS-CoV-2 mutations using a Cas12a-based sensing platform.
    He C; Lin C; Mo G; Xi B; Li AA; Huang D; Wan Y; Chen F; Liang Y; Zuo Q; Xu W; Feng D; Zhang G; Han L; Ke C; Du H; Huang L
    Biosens Bioelectron; 2022 Feb; 198():113857. PubMed ID: 34894625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Laverack M; Tallmadge RL; Venugopalan R; Cronk B; Zhang X; Rauh R; Saunders A; Nelson WM; Plocharczyk E; Diel DG
    Arch Virol; 2021 Sep; 166(9):2551-2561. PubMed ID: 34259914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of SARS-CoV-2 RNA in Upper Respiratory Swap Samples by Pooling Method.
    Tok YT; Kuşkucu MA; Erdem H; Sarıbal D; Salman Yılmaz S; Nohut OK; Karaali R; Balkan İİ; Mete B; Tabak ÖF; Aygün G; Midilli K
    Balkan Med J; 2022 Jan; 39(1):48-54. PubMed ID: 34928231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection.
    Buchta C; Camp JV; Jovanovic J; Radler U; Benka B; Puchhammer-Stöckl E; Müller MM; Griesmacher A; Aberle SW; Görzer I
    Clin Chem Lab Med; 2022 Jan; 60(2):291-298. PubMed ID: 34751522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genomics and epidemiology of SARS-CoV-2 lineage].
    Sukegawa S; Takeuchi H
    Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brief comparative evaluation of six open one-step RT-qPCR mastermixes for the detection of SARS-CoV-2 RNA using a Taqman probe.
    Haddar C; Verhoeven PO; Bourlet T; Pozzetto B; Pillet S
    J Clin Virol; 2020 Nov; 132():104636. PubMed ID: 33099260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid Automated Screening for SARS-CoV-2 B.1.617 Lineage Variants (Delta/Kappa) through a Versatile Toolset of qPCR-Based SNP Detection.
    Nörz D; Grunwald M; Tang HT; Olearo F; Günther T; Robitaille A; Fischer N; Grundhoff A; Aepfelbacher M; Pfefferle S; Lütgehetmann M
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Rapid Method for Generating Infectious SARS-CoV-2 and Variants Using Mutagenesis and Circular Polymerase Extension Cloning.
    Kim BK; Choi WS; Jeong JH; Oh S; Park JH; Yun YS; Min SC; Kang DH; Kim EG; Ryu H; Kim HK; Baek YH; Choi YK; Song MS
    Microbiol Spectr; 2023 Mar; 11(2):e0338522. PubMed ID: 36877070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Designing In-House SARS-CoV-2 RT-qPCR Assay for Variant of Concerns.
    Ergoren MC; Tuncel G; Ozverel CS; Sanlidag T
    Glob Med Genet; 2022 Sep; 9(3):252-257. PubMed ID: 36147624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genotyping SARS-CoV-2 Variants Using Ratiometric Nucleic Acid Barcode Panels.
    Kozlowski HN; Malekjahani A; Li VYC; Lekuti AA; Perusini S; Bell NG; Voisin V; Pouyabahar D; Pai S; Bader GD; Mubareka S; Gubbay JB; Chan WCW
    Anal Chem; 2023 Apr; 95(14):5877-5885. PubMed ID: 37000033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.